Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanoset was a biotechnology company focused on the development of nanotechnology-based bone graft substitutes and orthopedic solutions. The company's primary technology involved a calcium phosphate-based nanoparticle system designed to mimic the natural structure of human bone, promoting faster and more effective bone regeneration. Its lead product, NanoSet, was developed as an injectable or moldable bone void filler for use in orthopedic and dental surgeries. In 2012, the company's assets and technology were acquired by Exactech, a global medical device company, to enhance its biologics portfolio. Today, the NanoSet technology continues to be marketed as part of Exactech's orthopedic surgical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanoset.